We are dedicated to providing resources to patients, practicing clinicians, and all individuals concerned w/ improving the care of patients with kidney disease.
📈 In IgA nephropathy, a high Cholesterol-HDL-Glucose (CHG) index > 5.29 predicts poorer kidney survival.
⚠️ Patients showed an 84% greater risk of renal decline.
Metabolic imbalance = worse renal outcomes.
#IgAN#Nephrology#MetabolicSyndromepubmed.ncbi.nlm.nih.gov/4110…
In IgA nephropathy, a higher neutrophil-to-lymphocyte ratio (NLR) predicts early kidney decline.
🩸 Inflammation marker tied to lower eGFR & worse clinical profile.
📊 NLR could serve as a simple risk tool for IgAN progression.
#IgAN#Nephrology#eGFRpubmed.ncbi.nlm.nih.gov/4113…
High glucose triggers O-GlcNAcylation of ACSL4, driving ferroptosis in kidney cells 🧬
Knocking down OGT protected against renal damage in diabetic nephropathy models.
🔍 A new path toward targeted kidney protection.
#Nephrology#KidneyHealth#Ferroptosispubmed.ncbi.nlm.nih.gov/4113…
🏃♂️💚 New study of 119K+ Americans with Type 2 diabetes shows:
Even modest physical activity = big health gains.
Inactive → “Good health” ↑ 2.6× with regular movement.
Perfection isn’t required—progress matters.
#Diabetes#KidneyHealth#CVDpubmed.ncbi.nlm.nih.gov/4113…
🧬 Nanoparticle biomolecular coronas may revolutionize cancer detection.
Polystyrene & silica NPs with tailored surfaces distinguished healthy vs cancer patients — even specific cancers (ovarian, kidney). Fast, low-cost, blood-based diagnostics ahead!
pubmed.ncbi.nlm.nih.gov/4113…
#FACTtrial: In DNA-JB9 + Fibrillary Glomerulopathy, Acthar Gel cut proteinuria > 70% at 12 mo (P < 0.02). Adding tacrolimus offered no extra benefit. Acthar Gel alone is an effective antiproteinuric option for this ultra-rare kidney disease. #Nephrologypubmed.ncbi.nlm.nih.gov/4098…
🧬 Phase 3 ALIGN trial: Atrasentan cut proteinuria by 36% vs placebo in IgA nephropathy with favorable safety. No cardiac failure or severe edema observed.
Promising step toward better outcomes in #IgAN.
#Nephrology#KidneyHealthpubmed.ncbi.nlm.nih.gov/3946…